767 related articles for article (PubMed ID: 9480979)
1. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
[TBL] [Abstract][Full Text] [Related]
2. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
[TBL] [Abstract][Full Text] [Related]
3. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
4. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
[TBL] [Abstract][Full Text] [Related]
5. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
[TBL] [Abstract][Full Text] [Related]
6. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
7. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
[TBL] [Abstract][Full Text] [Related]
8. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
10. Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles.
Kobayashi H; Song Y; Hoon DS; Appella E; Celis E
Cancer Res; 2001 Jun; 61(12):4773-8. PubMed ID: 11406551
[TBL] [Abstract][Full Text] [Related]
11. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
[TBL] [Abstract][Full Text] [Related]
12. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
[TBL] [Abstract][Full Text] [Related]
13. Differing T-cell requirements for recombinant retrovirus vaccines.
Hasenkrug KJ; Brooks DM; Nishio J; Chesebro B
J Virol; 1996 Jan; 70(1):368-72. PubMed ID: 8523549
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes.
Takagi A; Matsui M; Ohno S; Duan H; Moriya O; Kobayashi N; Oda H; Mori M; Kobayashi A; Taneichi M; Uchida T; Akatsuka T
Clin Vaccine Immunol; 2009 Oct; 16(10):1383-92. PubMed ID: 19675224
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
16. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
17. Restriction of Friend virus-induced erythroid cell proliferation by CD4+ T-lymphocytes that recognize a single gp70 epitope.
Miyazawa M; Fujisawa R
Leukemia; 1997 Apr; 11 Suppl 3():227-9. PubMed ID: 9209349
[TBL] [Abstract][Full Text] [Related]
18. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
[TBL] [Abstract][Full Text] [Related]
19. Functional memory CD8+ T cells can be generated in vivo without evident T help.
Andrews MR; Peters T; Khammanivong V; Leggatt GR; Frazer IH; Fernando GJ
Vaccine; 2004 Dec; 23(6):739-42. PubMed ID: 15542197
[TBL] [Abstract][Full Text] [Related]
20. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
